nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—enteric nervous system—Crohn's disease	0.126	0.285	CbGeAlD
Lurasidone—HTR7—myenteric nerve plexus—Crohn's disease	0.0952	0.216	CbGeAlD
Lurasidone—HTR2A—enteric nervous system—Crohn's disease	0.0784	0.178	CbGeAlD
Lurasidone—HTR2A—myenteric nerve plexus—Crohn's disease	0.0594	0.135	CbGeAlD
Lurasidone—HTR7—mouth—Crohn's disease	0.0163	0.0369	CbGeAlD
Lurasidone—HTR7—epithelium—Crohn's disease	0.00948	0.0215	CbGeAlD
Lurasidone—HTR7—smooth muscle tissue—Crohn's disease	0.00913	0.0207	CbGeAlD
Lurasidone—Upset stomach—Mesalazine—Crohn's disease	0.00851	0.0209	CcSEcCtD
Lurasidone—ADRA2C—mammalian vulva—Crohn's disease	0.00756	0.0171	CbGeAlD
Lurasidone—HTR7—digestive system—Crohn's disease	0.00721	0.0163	CbGeAlD
Lurasidone—Breast disorder—Mercaptopurine—Crohn's disease	0.00674	0.0165	CcSEcCtD
Lurasidone—Breast pain—Mesalazine—Crohn's disease	0.00639	0.0157	CcSEcCtD
Lurasidone—Amenorrhoea—Mesalazine—Crohn's disease	0.00635	0.0155	CcSEcCtD
Lurasidone—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00622	0.0152	CcSEcCtD
Lurasidone—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00613	0.015	CcSEcCtD
Lurasidone—ADRA2A—mammalian vulva—Crohn's disease	0.00603	0.0137	CbGeAlD
Lurasidone—HTR2A—epithelium—Crohn's disease	0.00591	0.0134	CbGeAlD
Lurasidone—Embolism venous—Prednisone—Crohn's disease	0.00585	0.0143	CcSEcCtD
Lurasidone—HTR2A—smooth muscle tissue—Crohn's disease	0.00569	0.0129	CbGeAlD
Lurasidone—Neck pain—Mesalazine—Crohn's disease	0.00564	0.0138	CcSEcCtD
Lurasidone—Abnormal dreams—Mesalazine—Crohn's disease	0.00551	0.0135	CcSEcCtD
Lurasidone—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00544	0.0133	CcSEcCtD
Lurasidone—HTR2A—digestive system—Crohn's disease	0.0045	0.0102	CbGeAlD
Lurasidone—Malnutrition—Mercaptopurine—Crohn's disease	0.00449	0.011	CcSEcCtD
Lurasidone—Increased appetite—Mesalazine—Crohn's disease	0.00431	0.0106	CcSEcCtD
Lurasidone—Suicidal ideation—Prednisone—Crohn's disease	0.00421	0.0103	CcSEcCtD
Lurasidone—CYP3A4—digestive system—Crohn's disease	0.00416	0.00943	CbGeAlD
Lurasidone—Anaemia—Mercaptopurine—Crohn's disease	0.00415	0.0102	CcSEcCtD
Lurasidone—Lethargy—Mesalazine—Crohn's disease	0.00413	0.0101	CcSEcCtD
Lurasidone—Osteoarthritis—Mesalazine—Crohn's disease	0.00405	0.00992	CcSEcCtD
Lurasidone—Leukopenia—Mercaptopurine—Crohn's disease	0.00402	0.00985	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0038	0.0093	CcSEcCtD
Lurasidone—Blood creatinine increased—Mesalazine—Crohn's disease	0.00379	0.00929	CcSEcCtD
Lurasidone—ADRA2C—lymph node—Crohn's disease	0.00379	0.00858	CbGeAlD
Lurasidone—Abdominal pain upper—Mesalazine—Crohn's disease	0.0037	0.00906	CcSEcCtD
Lurasidone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.0037	0.00906	CcSEcCtD
Lurasidone—Abdominal discomfort—Azathioprine—Crohn's disease	0.00368	0.00902	CcSEcCtD
Lurasidone—Breast disorder—Mesalazine—Crohn's disease	0.00366	0.00896	CcSEcCtD
Lurasidone—Nasopharyngitis—Mesalazine—Crohn's disease	0.00362	0.00887	CcSEcCtD
Lurasidone—Gastritis—Mesalazine—Crohn's disease	0.00358	0.00878	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00357	0.00875	CcSEcCtD
Lurasidone—Skin disorder—Mercaptopurine—Crohn's disease	0.00356	0.00872	CcSEcCtD
Lurasidone—Influenza—Mesalazine—Crohn's disease	0.0035	0.00857	CcSEcCtD
Lurasidone—Dysphagia—Mesalazine—Crohn's disease	0.0035	0.00857	CcSEcCtD
Lurasidone—Eosinophilia—Mesalazine—Crohn's disease	0.00346	0.00849	CcSEcCtD
Lurasidone—Infestation—Azathioprine—Crohn's disease	0.00342	0.00839	CcSEcCtD
Lurasidone—Infestation NOS—Azathioprine—Crohn's disease	0.00342	0.00839	CcSEcCtD
Lurasidone—Angina pectoris—Mesalazine—Crohn's disease	0.00341	0.00835	CcSEcCtD
Lurasidone—Amenorrhoea—Prednisone—Crohn's disease	0.00336	0.00823	CcSEcCtD
Lurasidone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00335	0.00822	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00334	0.00818	CcSEcCtD
Lurasidone—Dysuria—Mesalazine—Crohn's disease	0.00327	0.00802	CcSEcCtD
Lurasidone—Neutropenia—Mesalazine—Crohn's disease	0.00327	0.00802	CcSEcCtD
Lurasidone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00324	0.00794	CcSEcCtD
Lurasidone—Agranulocytosis—Azathioprine—Crohn's disease	0.0032	0.00783	CcSEcCtD
Lurasidone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00319	0.00781	CcSEcCtD
Lurasidone—Weight increased—Mesalazine—Crohn's disease	0.00318	0.0078	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00316	0.00775	CcSEcCtD
Lurasidone—Infestation NOS—Mesalazine—Crohn's disease	0.00312	0.00764	CcSEcCtD
Lurasidone—Infestation—Mesalazine—Crohn's disease	0.00312	0.00764	CcSEcCtD
Lurasidone—Renal failure—Mesalazine—Crohn's disease	0.00307	0.00751	CcSEcCtD
Lurasidone—Urinary tract infection—Mesalazine—Crohn's disease	0.00303	0.00743	CcSEcCtD
Lurasidone—ADRA2A—lymph node—Crohn's disease	0.00302	0.00684	CbGeAlD
Lurasidone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00295	0.00723	CcSEcCtD
Lurasidone—Agranulocytosis—Mesalazine—Crohn's disease	0.00291	0.00713	CcSEcCtD
Lurasidone—Urinary tract disorder—Mesalazine—Crohn's disease	0.00277	0.00678	CcSEcCtD
Lurasidone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00275	0.00674	CcSEcCtD
Lurasidone—Arrhythmia—Azathioprine—Crohn's disease	0.00275	0.00673	CcSEcCtD
Lurasidone—Urethral disorder—Mesalazine—Crohn's disease	0.00274	0.00673	CcSEcCtD
Lurasidone—Eye disorder—Mesalazine—Crohn's disease	0.00262	0.00641	CcSEcCtD
Lurasidone—Cardiac disorder—Mesalazine—Crohn's disease	0.0026	0.00637	CcSEcCtD
Lurasidone—Angiopathy—Mesalazine—Crohn's disease	0.00254	0.00622	CcSEcCtD
Lurasidone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00251	0.00615	CcSEcCtD
Lurasidone—Anaemia—Azathioprine—Crohn's disease	0.00247	0.00606	CcSEcCtD
Lurasidone—Diabetes mellitus—Prednisone—Crohn's disease	0.00246	0.00603	CcSEcCtD
Lurasidone—Mental disorder—Mesalazine—Crohn's disease	0.00245	0.00601	CcSEcCtD
Lurasidone—Malaise—Azathioprine—Crohn's disease	0.00241	0.00591	CcSEcCtD
Lurasidone—Flatulence—Mesalazine—Crohn's disease	0.0024	0.00589	CcSEcCtD
Lurasidone—Leukopenia—Azathioprine—Crohn's disease	0.0024	0.00587	CcSEcCtD
Lurasidone—Back pain—Mesalazine—Crohn's disease	0.00236	0.00578	CcSEcCtD
Lurasidone—Muscle spasms—Mesalazine—Crohn's disease	0.00234	0.00574	CcSEcCtD
Lurasidone—Vomiting—Mercaptopurine—Crohn's disease	0.00233	0.00571	CcSEcCtD
Lurasidone—Rash—Mercaptopurine—Crohn's disease	0.00231	0.00566	CcSEcCtD
Lurasidone—Dermatitis—Mercaptopurine—Crohn's disease	0.00231	0.00566	CcSEcCtD
Lurasidone—Vision blurred—Mesalazine—Crohn's disease	0.0023	0.00563	CcSEcCtD
Lurasidone—Tremor—Mesalazine—Crohn's disease	0.00228	0.0056	CcSEcCtD
Lurasidone—Increased appetite—Prednisone—Crohn's disease	0.00228	0.00559	CcSEcCtD
Lurasidone—Myalgia—Azathioprine—Crohn's disease	0.00228	0.00558	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00226	0.00554	CcSEcCtD
Lurasidone—Anaemia—Mesalazine—Crohn's disease	0.00225	0.00552	CcSEcCtD
Lurasidone—Angioedema—Mesalazine—Crohn's disease	0.00223	0.00546	CcSEcCtD
Lurasidone—Malaise—Mesalazine—Crohn's disease	0.0022	0.00539	CcSEcCtD
Lurasidone—Vertigo—Mesalazine—Crohn's disease	0.00219	0.00537	CcSEcCtD
Lurasidone—Syncope—Mesalazine—Crohn's disease	0.00219	0.00536	CcSEcCtD
Lurasidone—Lethargy—Prednisone—Crohn's disease	0.00219	0.00535	CcSEcCtD
Lurasidone—Leukopenia—Mesalazine—Crohn's disease	0.00218	0.00535	CcSEcCtD
Lurasidone—Nausea—Mercaptopurine—Crohn's disease	0.00218	0.00533	CcSEcCtD
Lurasidone—Infection—Azathioprine—Crohn's disease	0.00217	0.00532	CcSEcCtD
Lurasidone—Loss of consciousness—Mesalazine—Crohn's disease	0.00214	0.00525	CcSEcCtD
Lurasidone—Osteoarthritis—Prednisone—Crohn's disease	0.00214	0.00525	CcSEcCtD
Lurasidone—Skin disorder—Azathioprine—Crohn's disease	0.00212	0.0052	CcSEcCtD
Lurasidone—Hypertension—Mesalazine—Crohn's disease	0.0021	0.00516	CcSEcCtD
Lurasidone—Psychotic disorder—Prednisone—Crohn's disease	0.00209	0.00512	CcSEcCtD
Lurasidone—Myalgia—Mesalazine—Crohn's disease	0.00208	0.00508	CcSEcCtD
Lurasidone—Anxiety—Mesalazine—Crohn's disease	0.00207	0.00507	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00206	0.00505	CcSEcCtD
Lurasidone—Hypotension—Azathioprine—Crohn's disease	0.00204	0.005	CcSEcCtD
Lurasidone—Dry mouth—Mesalazine—Crohn's disease	0.00203	0.00497	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00199	0.00488	CcSEcCtD
Lurasidone—Infection—Mesalazine—Crohn's disease	0.00198	0.00484	CcSEcCtD
Lurasidone—Shock—Mesalazine—Crohn's disease	0.00196	0.0048	CcSEcCtD
Lurasidone—Nervous system disorder—Mesalazine—Crohn's disease	0.00195	0.00478	CcSEcCtD
Lurasidone—Tachycardia—Mesalazine—Crohn's disease	0.00194	0.00476	CcSEcCtD
Lurasidone—Skin disorder—Mesalazine—Crohn's disease	0.00193	0.00473	CcSEcCtD
Lurasidone—Hyperhidrosis—Mesalazine—Crohn's disease	0.00192	0.00471	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00189	0.00463	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00189	0.00462	CcSEcCtD
Lurasidone—Hypotension—Mesalazine—Crohn's disease	0.00186	0.00455	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00181	0.00444	CcSEcCtD
Lurasidone—Insomnia—Mesalazine—Crohn's disease	0.0018	0.00441	CcSEcCtD
Lurasidone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00179	0.00438	CcSEcCtD
Lurasidone—Dyspnoea—Mesalazine—Crohn's disease	0.00177	0.00435	CcSEcCtD
Lurasidone—Somnolence—Mesalazine—Crohn's disease	0.00177	0.00433	CcSEcCtD
Lurasidone—Dyspepsia—Mesalazine—Crohn's disease	0.00175	0.00429	CcSEcCtD
Lurasidone—Neutropenia—Prednisone—Crohn's disease	0.00173	0.00424	CcSEcCtD
Lurasidone—Decreased appetite—Mesalazine—Crohn's disease	0.00173	0.00424	CcSEcCtD
Lurasidone—Abdominal pain—Azathioprine—Crohn's disease	0.00173	0.00423	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00172	0.00421	CcSEcCtD
Lurasidone—Fatigue—Mesalazine—Crohn's disease	0.00172	0.0042	CcSEcCtD
Lurasidone—Erectile dysfunction—Prednisone—Crohn's disease	0.0017	0.00418	CcSEcCtD
Lurasidone—Weight increased—Prednisone—Crohn's disease	0.00168	0.00413	CcSEcCtD
Lurasidone—Hyperglycaemia—Prednisone—Crohn's disease	0.00167	0.00409	CcSEcCtD
Lurasidone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00163	0.00399	CcSEcCtD
Lurasidone—Abdominal pain—Mesalazine—Crohn's disease	0.00157	0.00385	CcSEcCtD
Lurasidone—Bradycardia—Prednisone—Crohn's disease	0.00151	0.0037	CcSEcCtD
Lurasidone—Diarrhoea—Azathioprine—Crohn's disease	0.00149	0.00366	CcSEcCtD
Lurasidone—Connective tissue disorder—Prednisone—Crohn's disease	0.00146	0.00357	CcSEcCtD
Lurasidone—Dizziness—Azathioprine—Crohn's disease	0.00144	0.00354	CcSEcCtD
Lurasidone—Asthenia—Mesalazine—Crohn's disease	0.00143	0.0035	CcSEcCtD
Lurasidone—Pruritus—Mesalazine—Crohn's disease	0.00141	0.00345	CcSEcCtD
Lurasidone—Vomiting—Azathioprine—Crohn's disease	0.00139	0.0034	CcSEcCtD
Lurasidone—Eye disorder—Prednisone—Crohn's disease	0.00138	0.00339	CcSEcCtD
Lurasidone—Rash—Azathioprine—Crohn's disease	0.00138	0.00337	CcSEcCtD
Lurasidone—Dermatitis—Azathioprine—Crohn's disease	0.00138	0.00337	CcSEcCtD
Lurasidone—Diarrhoea—Mesalazine—Crohn's disease	0.00136	0.00334	CcSEcCtD
Lurasidone—Angiopathy—Prednisone—Crohn's disease	0.00134	0.00329	CcSEcCtD
Lurasidone—Arrhythmia—Prednisone—Crohn's disease	0.00132	0.00324	CcSEcCtD
Lurasidone—Dizziness—Mesalazine—Crohn's disease	0.00132	0.00322	CcSEcCtD
Lurasidone—Mental disorder—Prednisone—Crohn's disease	0.0013	0.00318	CcSEcCtD
Lurasidone—Nausea—Azathioprine—Crohn's disease	0.0013	0.00318	CcSEcCtD
Lurasidone—Malnutrition—Prednisone—Crohn's disease	0.00129	0.00316	CcSEcCtD
Lurasidone—Vomiting—Mesalazine—Crohn's disease	0.00126	0.0031	CcSEcCtD
Lurasidone—Rash—Mesalazine—Crohn's disease	0.00125	0.00307	CcSEcCtD
Lurasidone—Dermatitis—Mesalazine—Crohn's disease	0.00125	0.00307	CcSEcCtD
Lurasidone—Vision blurred—Prednisone—Crohn's disease	0.00122	0.00298	CcSEcCtD
Lurasidone—Anaemia—Prednisone—Crohn's disease	0.00119	0.00292	CcSEcCtD
Lurasidone—Agitation—Prednisone—Crohn's disease	0.00119	0.0029	CcSEcCtD
Lurasidone—Nausea—Mesalazine—Crohn's disease	0.00118	0.0029	CcSEcCtD
Lurasidone—Angioedema—Prednisone—Crohn's disease	0.00118	0.00289	CcSEcCtD
Lurasidone—Malaise—Prednisone—Crohn's disease	0.00116	0.00285	CcSEcCtD
Lurasidone—Vertigo—Prednisone—Crohn's disease	0.00116	0.00284	CcSEcCtD
Lurasidone—Syncope—Prednisone—Crohn's disease	0.00116	0.00283	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisone—Crohn's disease	0.00113	0.00278	CcSEcCtD
Lurasidone—Convulsion—Prednisone—Crohn's disease	0.00112	0.00274	CcSEcCtD
Lurasidone—Hypertension—Prednisone—Crohn's disease	0.00111	0.00273	CcSEcCtD
Lurasidone—Myalgia—Prednisone—Crohn's disease	0.0011	0.00269	CcSEcCtD
Lurasidone—Anxiety—Prednisone—Crohn's disease	0.00109	0.00268	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00109	0.00267	CcSEcCtD
Lurasidone—Infection—Prednisone—Crohn's disease	0.00105	0.00256	CcSEcCtD
Lurasidone—Shock—Prednisone—Crohn's disease	0.00104	0.00254	CcSEcCtD
Lurasidone—Nervous system disorder—Prednisone—Crohn's disease	0.00103	0.00253	CcSEcCtD
Lurasidone—Tachycardia—Prednisone—Crohn's disease	0.00103	0.00252	CcSEcCtD
Lurasidone—Skin disorder—Prednisone—Crohn's disease	0.00102	0.00251	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisone—Crohn's disease	0.00102	0.00249	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000959	0.00235	CcSEcCtD
Lurasidone—Insomnia—Prednisone—Crohn's disease	0.000952	0.00233	CcSEcCtD
Lurasidone—Dyspepsia—Prednisone—Crohn's disease	0.000926	0.00227	CcSEcCtD
Lurasidone—Decreased appetite—Prednisone—Crohn's disease	0.000915	0.00224	CcSEcCtD
Lurasidone—Fatigue—Prednisone—Crohn's disease	0.000907	0.00222	CcSEcCtD
Lurasidone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000861	0.00211	CcSEcCtD
Lurasidone—Abdominal pain—Prednisone—Crohn's disease	0.000832	0.00204	CcSEcCtD
Lurasidone—Asthenia—Prednisone—Crohn's disease	0.000755	0.00185	CcSEcCtD
Lurasidone—Pruritus—Prednisone—Crohn's disease	0.000745	0.00182	CcSEcCtD
Lurasidone—Diarrhoea—Prednisone—Crohn's disease	0.00072	0.00176	CcSEcCtD
Lurasidone—Dizziness—Prednisone—Crohn's disease	0.000696	0.00171	CcSEcCtD
Lurasidone—Vomiting—Prednisone—Crohn's disease	0.000669	0.00164	CcSEcCtD
Lurasidone—Rash—Prednisone—Crohn's disease	0.000664	0.00163	CcSEcCtD
Lurasidone—Dermatitis—Prednisone—Crohn's disease	0.000663	0.00162	CcSEcCtD
Lurasidone—Nausea—Prednisone—Crohn's disease	0.000625	0.00153	CcSEcCtD
Lurasidone—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.000186	0.00123	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—IL3—Crohn's disease	0.000186	0.00123	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	0.000184	0.00122	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL3—Crohn's disease	0.000183	0.00122	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MLN—Crohn's disease	0.000183	0.00121	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000182	0.00121	CbGpPWpGaD
Lurasidone—ADRA2C—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000181	0.0012	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000181	0.0012	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	0.000181	0.0012	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RSPO3—Crohn's disease	0.00018	0.0012	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	0.000179	0.00119	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—RASGRP1—Crohn's disease	0.000177	0.00118	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	0.000176	0.00117	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000175	0.00116	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CCR6—Crohn's disease	0.000175	0.00116	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	0.000175	0.00116	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	0.000172	0.00114	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SEL1L—Crohn's disease	0.00017	0.00113	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTMR3—Crohn's disease	0.00017	0.00113	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.00017	0.00113	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00017	0.00113	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	0.000167	0.00111	CbGpPWpGaD
Lurasidone—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000165	0.00109	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RSPO3—Crohn's disease	0.000163	0.00108	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—FADS1—Crohn's disease	0.000163	0.00108	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR9—Crohn's disease	0.000161	0.00107	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—IL6—Crohn's disease	0.000161	0.00107	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	0.000161	0.00107	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—IL2RA—Crohn's disease	0.00016	0.00106	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000159	0.00106	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCR6—Crohn's disease	0.000159	0.00105	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000156	0.00104	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.000156	0.00104	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	0.000156	0.00104	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR9—Crohn's disease	0.000156	0.00104	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SEL1L—Crohn's disease	0.000155	0.00103	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—PTGER4—Crohn's disease	0.000154	0.00102	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000154	0.00102	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—CXCL8—Crohn's disease	0.000153	0.00102	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GPX4—Crohn's disease	0.000153	0.00101	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	0.000152	0.00101	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000151	0.00101	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GPR65—Crohn's disease	0.00015	0.000995	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	0.000149	0.000992	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000149	0.00099	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GCKR—Crohn's disease	0.000147	0.00098	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000147	0.000979	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000146	0.000971	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	0.000146	0.000971	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GPR65—Crohn's disease	0.000145	0.000963	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—IL3—Crohn's disease	0.000144	0.000959	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000144	0.000959	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000144	0.000958	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCR6—Crohn's disease	0.000144	0.000957	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000142	0.000944	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR9—Crohn's disease	0.000141	0.00094	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—IL2RA—Crohn's disease	0.000141	0.000937	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	0.00014	0.000928	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00014	0.000928	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR9—Crohn's disease	0.000139	0.000925	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.000138	0.00092	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000138	0.000915	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000137	0.000913	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.000136	0.0009	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000132	0.00088	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GPR65—Crohn's disease	0.000132	0.000874	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL3—Crohn's disease	0.000131	0.000871	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000131	0.000871	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—IL3—Crohn's disease	0.000131	0.000871	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000131	0.000869	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RBX1—Crohn's disease	0.00013	0.000866	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.00013	0.000864	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GPR65—Crohn's disease	0.000129	0.00086	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	0.000129	0.000857	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000129	0.000855	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL2RA—Crohn's disease	0.000128	0.000851	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PTGER4—Crohn's disease	0.000127	0.000843	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.000127	0.000843	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000127	0.000842	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.000127	0.000842	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000126	0.000839	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000125	0.000831	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000125	0.000829	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GPX4—Crohn's disease	0.000124	0.000824	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GCKR—Crohn's disease	0.00012	0.000796	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL3—Crohn's disease	0.000119	0.000791	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.000118	0.000782	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.000117	0.000779	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000117	0.000778	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL3—Crohn's disease	0.000117	0.000778	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—ALB—Crohn's disease	0.000116	0.000769	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000115	0.000765	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—UBE2D1—Crohn's disease	0.000114	0.000759	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000113	0.000754	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000113	0.000754	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000113	0.000752	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RIPK2—Crohn's disease	0.000111	0.000736	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	0.00011	0.00073	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL3—Crohn's disease	0.000108	0.000718	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—JAK2—Crohn's disease	0.000108	0.000715	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR6—Crohn's disease	0.000107	0.000709	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000107	0.000708	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—IL6—Crohn's disease	0.000105	0.000696	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000105	0.000695	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RASGRP1—Crohn's disease	0.000104	0.000694	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	0.000103	0.000686	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000103	0.000684	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000101	0.000672	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	9.96e-05	0.000662	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	9.8e-05	0.000651	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.77e-05	0.000649	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RBX1—Crohn's disease	9.65e-05	0.000641	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	9.49e-05	0.000631	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—JAK2—Crohn's disease	9.48e-05	0.00063	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SOCS1—Crohn's disease	9.47e-05	0.000629	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—ALB—Crohn's disease	9.4e-05	0.000625	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	9.4e-05	0.000624	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR6—Crohn's disease	9.37e-05	0.000623	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	9.34e-05	0.000621	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR6—Crohn's disease	9.22e-05	0.000613	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	9.19e-05	0.00061	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	9.18e-05	0.00061	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	9.09e-05	0.000604	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	9.03e-05	0.0006	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—TYK2—Crohn's disease	9.03e-05	0.0006	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	8.92e-05	0.000593	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—JAK2—Crohn's disease	8.74e-05	0.000581	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CXCL8—Crohn's disease	8.65e-05	0.000575	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—JAK2—Crohn's disease	8.61e-05	0.000572	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	8.52e-05	0.000566	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RBX1—Crohn's disease	8.48e-05	0.000563	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	8.47e-05	0.000562	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	8.39e-05	0.000557	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RBX1—Crohn's disease	8.34e-05	0.000554	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	8.33e-05	0.000554	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PTGER4—Crohn's disease	8.25e-05	0.000548	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	8.22e-05	0.000546	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	8.21e-05	0.000545	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	8.2e-05	0.000545	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	8.19e-05	0.000544	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SMAD3—Crohn's disease	8.17e-05	0.000543	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	8.12e-05	0.000539	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL3—Crohn's disease	8.01e-05	0.000532	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	7.94e-05	0.000528	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CXCL8—Crohn's disease	7.86e-05	0.000522	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL3—Crohn's disease	7.75e-05	0.000515	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	7.74e-05	0.000514	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	7.59e-05	0.000504	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL2RA—Crohn's disease	7.57e-05	0.000503	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	7.49e-05	0.000498	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	7.46e-05	0.000496	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	7.43e-05	0.000494	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	7.39e-05	0.000491	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	7.31e-05	0.000486	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.24e-05	0.000481	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RIPK2—Crohn's disease	7.21e-05	0.000479	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	7.09e-05	0.000471	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL3—Crohn's disease	7.03e-05	0.000467	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.03e-05	0.000467	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.01e-05	0.000466	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL3—Crohn's disease	6.92e-05	0.00046	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	6.8e-05	0.000452	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	6.8e-05	0.000452	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	6.79e-05	0.000451	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	6.69e-05	0.000444	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	6.69e-05	0.000444	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	6.65e-05	0.000442	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	6.47e-05	0.00043	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	6.45e-05	0.000429	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.41e-05	0.000426	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.38e-05	0.000424	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL3—Crohn's disease	6.29e-05	0.000418	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	6.21e-05	0.000412	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	6.17e-05	0.00041	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	6.17e-05	0.00041	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SOCS1—Crohn's disease	6.16e-05	0.000409	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	6.09e-05	0.000404	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	6.07e-05	0.000403	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	6.06e-05	0.000403	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.06e-05	0.000402	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—TYK2—Crohn's disease	5.87e-05	0.00039	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	5.86e-05	0.000389	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	5.82e-05	0.000387	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	5.78e-05	0.000384	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—FADS1—Crohn's disease	5.64e-05	0.000375	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	5.63e-05	0.000374	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	5.63e-05	0.000374	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	5.61e-05	0.000373	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—JAK2—Crohn's disease	5.6e-05	0.000372	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.54e-05	0.000368	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	5.52e-05	0.000367	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	5.51e-05	0.000366	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	5.51e-05	0.000366	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	5.43e-05	0.000361	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TYK2—Crohn's disease	5.33e-05	0.000354	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SMAD3—Crohn's disease	5.32e-05	0.000353	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX4—Crohn's disease	5.28e-05	0.000351	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	5.26e-05	0.000349	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	5.23e-05	0.000348	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	5.11e-05	0.00034	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCKR—Crohn's disease	5.1e-05	0.000339	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—JAK2—Crohn's disease	5.09e-05	0.000338	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.04e-05	0.000335	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	5.03e-05	0.000334	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	5.01e-05	0.000333	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL2RA—Crohn's disease	4.92e-05	0.000327	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	4.84e-05	0.000322	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	4.76e-05	0.000316	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ALB—Crohn's disease	4.69e-05	0.000312	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCL8—Crohn's disease	4.64e-05	0.000308	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	4.58e-05	0.000304	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—Crohn's disease	4.41e-05	0.000293	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	4.41e-05	0.000293	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—Crohn's disease	4.1e-05	0.000273	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.95e-05	0.000263	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	3.82e-05	0.000254	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—Crohn's disease	3.81e-05	0.000253	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—JAK2—Crohn's disease	3.77e-05	0.00025	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—STAT3—Crohn's disease	3.73e-05	0.000248	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	3.65e-05	0.000242	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.47e-05	0.00023	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.44e-05	0.000229	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.41e-05	0.000227	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—Crohn's disease	3.33e-05	0.000222	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	3.33e-05	0.000221	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—JAK2—Crohn's disease	3.31e-05	0.00022	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.27e-05	0.000217	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—JAK2—Crohn's disease	3.26e-05	0.000216	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	3.17e-05	0.00021	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	3.11e-05	0.000206	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL8—Crohn's disease	3.02e-05	0.000201	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.97e-05	0.000197	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.96e-05	0.000197	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.87e-05	0.000191	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.83e-05	0.000188	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.77e-05	0.000184	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.7e-05	0.00018	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.68e-05	0.000178	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—Crohn's disease	2.61e-05	0.000173	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.57e-05	0.000171	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.43e-05	0.000161	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.39e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	2.17e-05	0.000144	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.93e-05	0.000128	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.87e-05	0.000124	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—Crohn's disease	1.7e-05	0.000113	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.67e-05	0.000111	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—Crohn's disease	1.62e-05	0.000108	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.52e-05	0.000101	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.42e-05	9.44e-05	CbGpPWpGaD
